Humana (NYSE:HUM) Sees Large Volume Increase – What’s Next?

Humana Inc. (NYSE:HUM) shares saw unusually-high trading volume on Wednesday . Approximately 2,624,380 shares were traded during mid-day trading, an increase of 61% from the previous session’s volume of 1,631,849 shares.The stock last traded at $197.6110 and had previously closed at $207.93.

Key Headlines Impacting Humana

Here are the key news stories impacting Humana this week:

• Positive Sentiment: Upcoming catalyst — Humana will present fourth‑quarter and full‑year 2025 results on Feb. 6, giving management a near‑term opportunity to address rate pressure and update guidance. Humana to Present Fourth-Quarter and Full-Year 2025 Results on 6 February
• Neutral Sentiment: Analyst/market debate — articles are weighing whether the lower share price is a buying opportunity or a “value trap,” reflecting differing views on Humana’s ability to absorb tighter CMS rates. Is Humana Stock Now A Value Trap At $200?
• Negative Sentiment: Policy shock — the administration proposed keeping Medicare Advantage rates roughly flat (average ~0.09% increase), removing an expected tailwind for MA revenue growth and triggering the sector rout. Trump Administration proposes keeping steady Medicare rates paid to insurers, WSJ reports
• Negative Sentiment: Market reaction — large intraday declines across UnitedHealth, Humana, CVS and peers as investors price in tighter reimbursement and margin risk. Health insurers tumble after Trump administration proposes keeping Medicare Advantage rates flat next year
• Negative Sentiment: Direct Humana impact — headlines report a steep one‑day decline for HUM tied to the CMS update, and the stock has tested 52‑week lows amid the rout. Humana (HUM) Falls 21% on Medicare Payment Update
• Negative Sentiment: Margin pressure risk — coverage of tight CMS rates alongside expanding at‑home cardiac care highlights a potential cost/reimbursement mismatch for Humana’s MA business. Humana Faces Tight CMS Rates As At Home Cardiac Care Expands
• Negative Sentiment: Network/contract headwinds — a regional provider (Queen’s) is reported to be considering cutting ties with a for‑profit Medicare insurer, an example of local contract risk that could affect access/networks in specific markets. Queen’s May Cut Ties With This For-Profit Medicare Insurer
• Negative Sentiment: Technical/price action — coverage notes Humana shares hit a 52‑week low amid the broader insurer sell‑off, signaling short‑term bearish momentum. Humana stock hits 52-week low at $206.60 amid challenging year

Wall Street Analysts Forecast Growth

HUM has been the topic of a number of analyst reports. Mizuho increased their price target on Humana from $300.00 to $345.00 and gave the company an “outperform” rating in a research report on Thursday, October 9th. Truist Financial reduced their target price on shares of Humana from $300.00 to $285.00 and set a “hold” rating on the stock in a report on Monday, November 10th. Sanford C. Bernstein reiterated an “outperform” rating and set a $344.00 price target on shares of Humana in a report on Tuesday, January 6th. Bank of America raised their price objective on shares of Humana from $280.00 to $300.00 and gave the company a “neutral” rating in a report on Friday, October 10th. Finally, Wells Fargo & Company cut shares of Humana from an “overweight” rating to a “cautious” rating in a research report on Wednesday, January 7th. Eight research analysts have rated the stock with a Buy rating, nine have given a Hold rating and five have issued a Sell rating to the company. According to MarketBeat.com, Humana currently has an average rating of “Hold” and an average price target of $293.37.

Humana Stock Performance

The firm’s fifty day moving average price is $258.31 and its 200-day moving average price is $264.92. The company has a current ratio of 2.02, a quick ratio of 2.02 and a debt-to-equity ratio of 0.68. The firm has a market cap of $23.34 billion, a price-to-earnings ratio of 18.20, a PEG ratio of 2.17 and a beta of 0.45.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.95 by $0.29. Humana had a return on equity of 12.86% and a net margin of 1.02%.The company had revenue of $32.65 billion for the quarter, compared to analyst estimates of $31.99 billion. During the same quarter last year, the company posted $4.16 earnings per share. The business’s quarterly revenue was up 11.1% compared to the same quarter last year. Analysts expect that Humana Inc. will post 16.47 earnings per share for the current year.

Institutional Investors Weigh In On Humana

Hedge funds and other institutional investors have recently modified their holdings of the stock. KLP Kapitalforvaltning AS lifted its position in shares of Humana by 5.5% in the fourth quarter. KLP Kapitalforvaltning AS now owns 46,070 shares of the insurance provider’s stock valued at $11,835,000 after acquiring an additional 2,400 shares in the last quarter. OVERSEA CHINESE BANKING Corp Ltd acquired a new position in Humana in the 4th quarter valued at about $272,000. Evergreen Capital Management LLC lifted its holdings in Humana by 145.0% in the 4th quarter. Evergreen Capital Management LLC now owns 2,288 shares of the insurance provider’s stock valued at $588,000 after purchasing an additional 1,354 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of Humana by 56.0% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 84,695 shares of the insurance provider’s stock worth $21,693,000 after purchasing an additional 30,402 shares during the last quarter. Finally, Krilogy Financial LLC grew its holdings in shares of Humana by 25.2% during the fourth quarter. Krilogy Financial LLC now owns 1,963 shares of the insurance provider’s stock worth $518,000 after buying an additional 395 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.